Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: Evidence for augmented biosynthesis
- 7 November 2008
- journal article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 107 (2-3), 150-157
- https://doi.org/10.1016/j.schres.2008.09.027
Abstract
Prior clinical studies suggest that chronic treatment with atypical antipsychotic medications increase erythrocyte and postmortem prefrontal cortex (PFC) omega-3 fatty acid composition in patients with schizophrenia (SZ). However, because human tissue phospholipid omega-3 fatty acid composition is potentially influenced by multiple extraneous variables, definitive evaluation of this putative mechanism of action requires an animal model. In the present study, we determined the effects of chronic treatment with the atypical antipsychotic risperidone (RISP, 3.0 mg/kg/d) on erythrocyte and PFC omega-3 fatty acid composition in rats maintained on a diet with or without the dietary omega-3 fatty acid precursor, alpha-linolenic acid (ALA, 18:3n-3). Chronic RISP treatment resulted in therapeutically-relevant plasma RISP and 9-OH-RISP concentrations (18 ± 2.6 ng/ml), and significantly increased erythrocyte docosahexaenoic acid (DHA, 22:6n-3, + 22%, p = 0.0003) and docosapentaenoic acid (22:5n-3, + 18%, p = 0.01) composition, and increased PFC DHA composition (+ 7%, p = 0.03) in rats maintained on the ALA+ diet. In contrast, chronic RISP did not alter erythrocyte or PFC omega-3 fatty acid composition in rats maintained on the ALA− diet. Chronic RISP treatment did not alter erythrocyte or PFC arachidonic acid (AA, 20:4n-6) composition. These data suggest that chronic RISP treatment significantly augments ALA−DHA biosynthesis, and preferentially increases peripheral and central membrane omega-3 fatty acid composition. Augmented omega-3 fatty acid biosynthesis and membrane composition represents a novel mechanism of action that may contribute in part to the efficacy of RISP in the treatment of SZ.Keywords
This publication has 55 references indexed in Scilit:
- Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorderPsychiatry Research, 2008
- Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patientsSchizophrenia Research, 2007
- Metabolomic mapping of atypical antipsychotic effects in schizophreniaMolecular Psychiatry, 2007
- Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medicationsSchizophrenia Research, 2007
- Clinical Pharmacokinetics of Atypical AntipsychoticsClinical Pharmacokinetics, 2007
- Identification of novel mutations inPEX2,PEX6,PEX10,PEX12, andPEX13in Zellweger spectrum patientsHuman Mutation, 2006
- Effect of Omega-3 Fatty Acids on the Lipid Profile of Patients Taking ClozapineAustralian & New Zealand Journal of Psychiatry, 2006
- Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: SchizophreniaAmerican Journal of Human Genetics, 2003
- Ethanol Consumption Alters Electroretinograms and Depletes Neural Tissues of Docosahexaenoic Acid in Rhesus Monkeys: Nutritional Consequences of a Low n‐3 Fatty Acid DietAlcohol: Clinical and Experimental Research, 2001
- Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994